OxyContin goes global — “We’re only just getting started”
OxyContin is a dying business in America. This is the third part of a Los Angeles Times investigation exploring the role of OxyContin in the nation’s opioid epidemic. With the nation in the grip of an opioid epidemic that has claimed more than 200,000 lives, the U.S. medical establishment is turning away from painkillers. Top health officials are discouraging primary care doctors from prescribing them for chronic pain, saying there is no proof they work long-term and substantial evidence they put patients at risk.